About: Ifetroban

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Ifetroban is a potent and selective thromboxane receptor antagonist. It has been studied in animal models for the treatment of cancer metastasis, myocardial ischemia, hypertension, stroke, thrombosis, cardiomyopathy, and for its effects on platelets. Clinical trials are evaluating the therapeutic safety and efficacy of oral ifetroban capsules for the treatment of cancer metastasis, cardiovascular disease, aspirin exacerbated respiratory disease, systemic sclerosis, and Duchenne muscular dystrophy.

Property Value
dbo:abstract
  • Ifetroban is a potent and selective thromboxane receptor antagonist. It has been studied in animal models for the treatment of cancer metastasis, myocardial ischemia, hypertension, stroke, thrombosis, cardiomyopathy, and for its effects on platelets. Clinical trials are evaluating the therapeutic safety and efficacy of oral ifetroban capsules for the treatment of cancer metastasis, cardiovascular disease, aspirin exacerbated respiratory disease, systemic sclerosis, and Duchenne muscular dystrophy. (en)
dbo:casNumber
  • 143443-90-7
dbo:chEMBL
  • 2146062
dbo:drugbank
  • DB12321
dbo:fdaUniiCode
  • E833KT807K
dbo:kegg
  • D04500
dbo:pubchem
  • 23724921
dbo:thumbnail
dbo:wikiPageID
  • 27152833 (xsd:integer)
dbo:wikiPageLength
  • 5118 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1081788180 (xsd:integer)
dbo:wikiPageWikiLink
dbp:atcPrefix
  • None (en)
dbp:c
  • 25 (xsd:integer)
dbp:casNumber
  • 143443 (xsd:integer)
dbp:chembl
  • 2146062 (xsd:integer)
dbp:chemspiderid
  • 58452 (xsd:integer)
dbp:drugbank
  • DB12321 (en)
dbp:h
  • 32 (xsd:integer)
dbp:iupacName
  • 3 (xsd:integer)
dbp:kegg
  • D04500 (en)
dbp:n
  • 2 (xsd:integer)
dbp:o
  • 5 (xsd:integer)
dbp:pubchem
  • 23724921 (xsd:integer)
dbp:smiles
  • O=Cc1nc[C@@H]4C2O[C@@H][C@@H]4Cc3ccccc3CCCO (en)
dbp:unii
  • E833KT807K (en)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • Ifetroban is a potent and selective thromboxane receptor antagonist. It has been studied in animal models for the treatment of cancer metastasis, myocardial ischemia, hypertension, stroke, thrombosis, cardiomyopathy, and for its effects on platelets. Clinical trials are evaluating the therapeutic safety and efficacy of oral ifetroban capsules for the treatment of cancer metastasis, cardiovascular disease, aspirin exacerbated respiratory disease, systemic sclerosis, and Duchenne muscular dystrophy. (en)
rdfs:label
  • Ifetroban (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License